Terns Pharmaceuticals, Inc.TERNNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank100
3Y CAGR+91.2%
5Y CAGR+12.4%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+91.2%/yr
vs +53.3%/yr prior
5Y CAGR
+12.4%/yr
Recent acceleration
Acceleration
+37.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
4 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$14.28M+7.5%
2024$13.28M+5.5%
2023$12.59M+516.4%
2022$2.04M+872.4%
2021$210000.00-97.4%
2020$7.97M+486.7%
2019$1.36M+267.0%
2018$370000.00-